UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 1, 2025
Accession Number:
0001104659-25-062436
Submission Type:
POS AM
CIK:
0001505512
Company Name:
Regulus Therapeutics Inc.
File Number:
333-236026